Integer Holdings (ITGR) Fundamentals 2026 — P/E 23.7x, Revenue Analysis | SniperIQ
Integer Holdings (ITGR) is a US-listed Healthcare company in Medical - Devices with a market capitalization of
Integer Holdings (ITGR) is a US-listed Healthcare company in Medical - Devices with a market capitalization of
Integer Holdings (ITGR) has a market capitalization of approximately
Integer Holdings's trailing twelve-month P/E ratio is 23.7x, with a price-to-book (P/B) of 1.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
Integer Holdings runs a net profit margin of 7.7%, a gross margin of 23.3%, and an operating margin of 10.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Integer Holdings reported revenue of
Integer Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Integer Holdings carries a debt-to-equity ratio of 0.81x and a current ratio of 3.75x, with a market beta of 0.64. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Integer Holdings (ITGR) the key facts are: market cap
Get Integer Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.